Synergy of Radiologic Tumor Burden, C-Reactive Protein, and Albumin with  Serum Lactate Dehydrogenase in the Prognostic Assessment of Pediatric and  Adult Malignancies: A Community-Based Clinical Study

Humera Usman, Tahir Mahmood Butt, Nisar Hussain, Nasir Khan, Amna Khalil, Aisha Khalil, Rabia Azhar, Nabeeha Azhar, Danish Sohail

Synergy of Radiologic Tumor Burden, C-Reactive Protein, and Albumin with Serum Lactate Dehydrogenase in the Prognostic Assessment of Pediatric and Adult Malignancies: A Community-Based Clinical Study

Authors

Humera Usman, Tahir Mahmood Butt, Nisar Hussain, Nasir Khan, Amna Khalil, Aisha Khalil, Rabia Azhar, Nabeeha Azhar, Danish Sohail

Keywords:

Lactate dehydrogenase, CRP, tumor burden

Abstract

Cancer prognosis requires reliable,accessible, and cost-effective biomarkers capable of reflecting tumor biology, systemicinflammation, and host nutritional status. Thepresent community-based clinical study

References

1. Sung H et al. Global cancer statistics update. CA Cancer J Clin. 2022.

2. Bray F et al. Cancer burden trends worldwide. Lancet Oncol. 2021.

Downloads

Published

2026-06-05

How to Cite

Humera Usman, Tahir Mahmood Butt, Nisar Hussain, Nasir Khan, Amna Khalil, Aisha Khalil, Rabia Azhar, Nabeeha Azhar, Danish Sohail. (2026). Synergy of Radiologic Tumor Burden, C-Reactive Protein, and Albumin with Serum Lactate Dehydrogenase in the Prognostic Assessment of Pediatric and Adult Malignancies: A Community-Based Clinical Study . International Journal of Pharmacy Research & Technology (IJPRT), 16(1), 3443–3447. Retrieved from https://www.ijprt.org/index.php/pub/article/view/2049